Our Board
Dr. Jogin Desai
CEO - Eyestem Research
Jogin is the Founder and CEO of Eyestem Research, a startup working to make stem cell therapeutics an affordable reality for multiple therapeutic indications, starting with dry age related macular degeneration. Eyestem’s first product aims to treat dry age related macular degeneration- a blinding, incurable disease that affects 170 M people worldwide. Jogin brings more than 15 years of experience in growing and nurturing businesses to his newest venture. Prior to Eyestem, he was part of the global leadership team at Quintiles and led their cardiac safety business from 2001 to 2007. More recently, he was the CEO of Cenduit, the world’s largest standalone clinical trial randomization company with offices in Bangalore, Basel, Philadelphia and North Carolina and a joint venture between Quintiles and Thermo Fisher Scientific.